News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
826,750 Results
Type
Article (75077)
Company Profile (662)
Press Release (750984)
Multimedia
Podcasts (156)
Webinars (26)
Section
Business (226855)
Career Advice (3728)
Deals (39245)
Drug Delivery (133)
Drug Development (89268)
Employer Resources (201)
FDA (17969)
Job Trends (17138)
News (387041)
Policy (38826)
Tag
Academia (3002)
Academic (1)
Accelerated approval (17)
Adcomms (35)
Allergies (119)
Alliances (56013)
ALS (137)
Alzheimer's disease (1648)
Antibody-drug conjugate (ADC) (206)
Approvals (17965)
Artificial intelligence (422)
Autoimmune disease (48)
Automation (23)
Bankruptcy (403)
Best Places to Work (12632)
BIOSECURE Act (22)
Biosimilars (150)
Biotechnology (440)
Bladder cancer (118)
Brain cancer (47)
Breast cancer (437)
Cancer (3543)
Cardiovascular disease (312)
Career advice (3184)
Career pathing (36)
CAR-T (231)
CDC (51)
Cell therapy (615)
Cervical cancer (29)
Clinical research (73520)
Collaboration (1293)
Company closure (4)
Compensation (868)
Complete response letters (51)
COVID-19 (2940)
CRISPR (78)
C-suite (514)
Cystic fibrosis (130)
Data (3838)
Decentralized trials (2)
Denatured (53)
Depression (100)
Diabetes (427)
Diagnostics (7044)
Digital health (28)
Diversity (11)
Diversity, equity & inclusion (49)
Drug discovery (188)
Drug pricing (168)
Drug shortages (36)
Duchenne muscular dystrophy (183)
Earnings (95359)
Editorial (53)
Employer branding (25)
Employer resources (169)
Events (131135)
Executive appointments (958)
FDA (20216)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (4)
Frontotemporal dementia (11)
Funding (1133)
Gene editing (165)
Generative AI (35)
Gene therapy (494)
GLP-1 (999)
Government (5302)
Grass and pollen (7)
Guidances (334)
Healthcare (20914)
HIV (47)
Huntington's disease (34)
IgA nephropathy (52)
Immunology and inflammation (226)
Immuno-oncology (19)
Indications (47)
Infectious disease (3159)
Inflammatory bowel disease (179)
Inflation Reduction Act (13)
Influenza (86)
Intellectual property (168)
Interviews (730)
IPO (17823)
IRA (59)
Job creations (4947)
Job search strategy (2592)
Kidney cancer (14)
Labor market (70)
Layoffs (625)
Leadership (31)
Legal (9920)
Liver cancer (90)
Longevity (12)
Lung cancer (511)
Lymphoma (251)
Machine learning (22)
Management (65)
Manufacturing (566)
MASH (121)
Medical device (14812)
Medtech (14830)
Mergers & acquisitions (22243)
Metabolic disorders (1086)
Multiple sclerosis (120)
NASH (23)
Neurodegenerative disease (184)
Neuropsychiatric disorders (50)
Neuroscience (2554)
NextGen: Class of 2025 (7639)
Non-profit (5093)
Now hiring (54)
Obesity (542)
Opinion (304)
Ovarian cancer (114)
Pain (156)
Pancreatic cancer (147)
Parkinson's disease (214)
Partnered (25)
Patents (387)
Patient recruitment (272)
Peanut (57)
People (64587)
Pharmaceutical (132)
Pharmacy benefit managers (25)
Phase I (22695)
Phase II (32073)
Phase III (24171)
Pipeline (2488)
Policy (281)
Postmarket research (3246)
Preclinical (10011)
Press Release (72)
Prostate cancer (175)
Psychedelics (49)
Radiopharmaceuticals (280)
Rare diseases (605)
Real estate (7141)
Recruiting (76)
Regulatory (26914)
Reports (64)
Research institute (2672)
Resumes & cover letters (580)
Rett syndrome (12)
RNA editing (15)
RSV (64)
Schizophrenia (121)
Series A (190)
Series B (142)
Service/supplier (27)
Sickle cell disease (77)
Special edition (25)
Spinal muscular atrophy (167)
Sponsored (40)
Startups (4212)
State (2)
Stomach cancer (17)
Supply chain (95)
Tariffs (83)
The Weekly (101)
Vaccines (1010)
Venture capital (63)
Weight loss (377)
Women's health (53)
Worklife (21)
Date
Today (1)
Last 7 days (532)
Last 30 days (2252)
Last 365 days (33017)
2025 (23427)
2024 (37887)
2023 (42567)
2022 (53927)
2021 (58722)
2020 (57663)
2019 (51302)
2018 (39083)
2017 (36792)
2016 (37682)
2015 (43671)
2014 (38264)
2013 (34207)
2012 (36155)
2011 (36239)
2010 (35567)
Location
Africa (1194)
Alabama (78)
Alaska (7)
Arizona (273)
Arkansas (14)
Asia (49369)
Australia (8427)
California (8952)
Canada (2718)
China (847)
Colorado (379)
Connecticut (398)
Delaware (241)
Europe (111365)
Florida (1317)
Georgia (305)
Hawaii (3)
Idaho (66)
Illinois (768)
India (46)
Indiana (433)
Iowa (19)
Japan (270)
Kansas (122)
Kentucky (35)
Louisiana (20)
Maine (75)
Maryland (1219)
Massachusetts (6729)
Michigan (293)
Minnesota (543)
Mississippi (4)
Missouri (113)
Montana (32)
Nebraska (26)
Nevada (102)
New Hampshire (75)
New Jersey (2469)
New Mexico (32)
New York (2439)
North Carolina (1359)
North Dakota (10)
Northern California (3989)
Ohio (279)
Oklahoma (19)
Oregon (47)
Pennsylvania (1862)
Puerto Rico (18)
Rhode Island (44)
South America (1565)
South Carolina (45)
South Dakota (1)
Southern California (3410)
Tennessee (141)
Texas (1389)
United States (33100)
Utah (267)
Virginia (237)
Washington D.C. (82)
Washington State (766)
West Virginia (4)
Wisconsin (90)
826,750 Results for "ucb japan co ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
MEDIPAL HOLDINGS and JCR Pharmaceuticals Sign Global Licensing and Japan Co-Development Agreement for JR-479, a Novel Therapy for GM2 Gangliosidosis
September 3, 2025
·
6 min read
Press Releases
Ocugen, Inc. and Kwangdong Pharmaceutical Co., Ltd. Complete License Agreement of OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in Korea
September 15, 2025
·
5 min read
Press Releases
UCB presents latest research and clinical advancement across leading epilepsy portfolio at International Epilepsy Congress
August 29, 2025
·
40 min read
Press Releases
NKGen Biotech, Inc. Announces Completion of NKMax Co., Ltd. Acquisition; Gains Full Control of Global Manufacturing and Intellectual Property Assets
September 10, 2025
·
8 min read
Press Releases
Amphastar Pharmaceuticals Bolsters Proprietary Pipeline Through Exclusive Licensing Agreement with Nanjing Anji Biotechnology Co., Ltd.
August 12, 2025
·
6 min read
Press Releases
Inari Medical Announces Reimbursement Approval for ClotTriever® Thrombectomy System in Japan and New Distribution Partnership with Medikit Co., Ltd.
December 3, 2024
·
4 min read
Press Releases
JCR Pharmaceuticals Selected for Japan’s Regenerative Medicine CDMO Subsidy Program
July 17, 2025
·
4 min read
Press Releases
Nuvaxovid® Now Approved in Japan Triggering Takeda Milestone Payment
September 5, 2025
·
4 min read
Press Releases
Ferring Japan announces PMDA Acceptance of NDA Filing for nadofaragene firadenovec
September 11, 2025
·
7 min read
Press Releases
Newron and EA Pharma (A Subsidiary of Eisai Co., Ltd.) Announce License Agreement for Evenamide in Japan and Other Asian Territories
December 13, 2024
·
11 min read
1 of 82,675
Next
